Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants
Felix Wussow, Mindy Kha, Katelyn Faircloth, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104457-104457
Open Access | Times Cited: 10

Showing 10 citing articles:

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Haiyun Yu, Fei Guan, Heather Miller, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Flavia Chiuppesi, John A. Zaia, Miguel-Angel Gutierrez-Franco, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 7
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants
Felix Wussow, Mindy Kha, Tae Hyun Kim, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Strategies for the Modification of Vaccinia Virus towards a Better Vaccine Vector
Hao Sun, Xinwen Chen, Yun Wang
Zoonoses (2025) Vol. 5, Iss. 1
Open Access
Optimization of a panel of behavioral tests for use in containment using a golden Syrian hamster model
Rachel A. Reyna, Jordyn Walker, Ashley Viveros, et al.
Journal of Virological Methods (2025), pp. 115132-115132
Open Access
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
Flavia Chiuppesi, John A. Zaia, Katelyn Faircloth, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104745-104745
Open Access | Times Cited: 18
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
Rana Abdelnabi, Patricia Pérez, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy
Flavia Chiuppesi, Sandra Ortega Francisco, Miguel-Angel Gutierrez, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1492-1492
Open Access | Times Cited: 3
Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adults
Flavia Chiuppesi, John A. Zaia, Sandra Ortega Francisco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top